» Articles » PMID: 31118097

Transcriptional Consequences of Impaired Immune Cell Responses Induced by Cystic Fibrosis Plasma Characterized Via Dual RNA Sequencing

Overview
Publisher Biomed Central
Specialty Genetics
Date 2019 May 24
PMID 31118097
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In cystic fibrosis (CF), impaired immune cell responses, driven by the dysfunctional CF transmembrane conductance regulator (CFTR) gene, may determine the disease severity but clinical heterogeneity remains a major therapeutic challenge. The characterization of molecular mechanisms underlying impaired immune responses in CF may reveal novel targets with therapeutic potential. Therefore, we utilized simultaneous RNA sequencing targeted at identifying differentially expressed genes, transcripts, and miRNAs that characterize impaired immune responses triggered by CF and its phenotypes.

Methods: Peripheral blood mononuclear cells (PBMCs) extracted from a healthy donor were stimulated with plasma from CF patients (n = 9) and healthy controls (n = 3). The PBMCs were cultured (1 × 10 cells/well) for 9 h at 37 ° C in 5% CO. After culture, total RNA was extracted from each sample and used for simultaneous total RNA and miRNA sequencing.

Results: Analysis of expression signatures from peripheral blood mononuclear cells induced by plasma of CF patients and healthy controls identified 151 genes, 154 individual transcripts, and 41 miRNAs differentially expressed in CF compared to HC while the expression signatures of 285 genes, 241 individual transcripts, and seven miRNAs differed due to CF phenotypes. Top immune pathways influenced by CF included agranulocyte adhesion, diapedesis signaling, and IL17 signaling, while those influenced by CF phenotypes included natural killer cell signaling and PI3K signaling in B lymphocytes. Upstream regulator analysis indicated dysregulation of CCL5, NF-κB and IL1A due to CF while dysregulation of TREM1 and TP53 regulators were associated with CF phenotype. Five miRNAs showed inverse expression patterns with three target genes relevant in CF-associated impaired immune pathways while two miRNAs showed inverse expression patterns with two target genes relevant to a dysregulated immune pathway associated with CF phenotypes.

Conclusions: Our results indicate that miRNAs and individual transcript variants are relevant molecular targets contributing to impaired immune cell responses in CF.

Citing Articles

Discovery of dysregulated circular RNAs in whole blood transcriptomes from cystic fibrosis patients - implication of a role for cellular senescence in cystic fibrosis.

Salinas E, Macauley V, Keeling K, Edwards Y J Cyst Fibros. 2023; 22(4):683-693.

PMID: 37142522 PMC: 10947771. DOI: 10.1016/j.jcf.2023.04.021.


T-RHEX-RNAseq - a tagmentation-based, rRNA blocked, random hexamer primed RNAseq method for generating stranded RNAseq libraries directly from very low numbers of lysed cells.

Gustafsson C, Hauenstein J, Frengen N, Krstic A, Luc S, Mansson R BMC Genomics. 2023; 24(1):205.

PMID: 37069502 PMC: 10111750. DOI: 10.1186/s12864-023-09279-4.


CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons.

Zhang X, Moore C, Harmacek L, Domenico J, Rangaraj V, Ideozu J JCI Insight. 2022; 7(6).

PMID: 35315363 PMC: 8986072. DOI: 10.1172/jci.insight.152186.


CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Hisert K, Birkland T, Schoenfelt K, Long M, Grogan B, Carter S Front Pharmacol. 2020; 11:1219.

PMID: 33013356 PMC: 7461946. DOI: 10.3389/fphar.2020.01219.


Differential effects of the cystic fibrosis lung inflammatory environment on mesenchymal stromal cells.

Abreu S, Hampton T, Hoffman E, Dearborn J, Ashare A, Sidhu K Am J Physiol Lung Cell Mol Physiol. 2020; 319(6):L908-L925.

PMID: 32901521 PMC: 7792680. DOI: 10.1152/ajplung.00218.2020.


References
1.
Stricker T, Brown C, Bandlamudi C, McNerney M, Kittler R, Montoya V . Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression. PLoS Genet. 2017; 13(3):e1006589. PMC: 5367891. DOI: 10.1371/journal.pgen.1006589. View

2.
Levy H, Jia S, Pan A, Zhang X, Kaldunski M, Nugent M . Identification of molecular signatures of cystic fibrosis disease status with plasma-based functional genomics. Physiol Genomics. 2018; 51(1):27-41. PMC: 6383551. DOI: 10.1152/physiolgenomics.00109.2018. View

3.
Hensler M, Vancurova I, Becht E, Palata O, Strnad P, Tesarova P . Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients. Oncoimmunology. 2016; 5(4):e1102827. PMC: 4839342. DOI: 10.1080/2162402X.2015.1102827. View

4.
Hampton T, Ballok A, Bomberger J, Rutkowski M, Barnaby R, Coutermarsh B . Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?. Am J Physiol Lung Cell Mol Physiol. 2012; 303(6):L509-18. PMC: 3468482. DOI: 10.1152/ajplung.00226.2011. View

5.
Cohen T, Prince A . Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012; 18(4):509-19. PMC: 3577071. DOI: 10.1038/nm.2715. View